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Coccydynia can be difficult to resolve with conventional treatment options. Dorsal root ganglion (DRG) stimulation has recently
emerged as a treatment for chronic pain, but its application has not been described in the context of coccydynia. We used DRG
stimulation treatment in a patient suffering from intractable coccyx pain. At long-term follow-up, the patient experienced a decrease
in pain intensity and improvement in function, without any complications. DRG stimulation may be a treatment modality for
coccydynia refractory to other approaches.
1. Introduction
Coccydynia, or coccygodynia, is pain in the region of the
coccyx.The termwas first coined in 1859 by Simpson [1], who
also introduced the use of chloroform in anesthesia. Despite
the identification of coccygeal pain almost ∼150 years ago,
its treatment can be difficult in a select patient population in
whom the pain becomes chronic and debilitating. Treatment
options range from lifestyle modification and cushions, to
injections, to treatments as radical as resection of the coccyx
[2]. Recent reports have described the use of neuromodu-
lation techniques to treat chronic coccydynia [3]. The aim
of this report is to describe the use of dorsal root ganglion
(DRG) stimulation to treat chronic coccydynia.
Written informed consent was obtained from the patient
for publication of this case report.
2. Case Description
A 37-year-old female from Spain presented to our center in
August of 2017 with complaints of chronic intractable pain
in the coccyx. The patient suffered from this pain since 2009
when she sustained a coccyx fracture in a work-related slip
and fall injury while working as an airline stewardess in
Europe. At the time of presentation, the patient endorsed
10/10 coccyx pain on visual analog scale. She described the
pain as sharp, stinging, shooting, and radiating throughout
her bilateral lower extremities. Due to the injury, she was
forced to quit when her pain prevented her from performing
her duties. At the time of presentation, she could not sit or
walk for more than 10 minutes consecutively and required
special cushioning to be brought with her at all times.
Prior to presenting to our center, she had been evaluated
and treated by pain management physicians, orthopedic
surgeons, and multiple urgent care clinicians in both Spain
and the UK. Her past treatments in Europe includedmultiple
coccygeal blocks, trigger point injections, epidural steroid
injections, and a conventional spinal cord stimulator in 2011.
The spinal cord stimulation therapy consisted of anANSGen-
esis (company acquired in 2005 by St. Jude Medical, which
was subsequently purchased byAbbot) spinal cord stimulator
with one octode lead placed through the sacrococcygeal hia-
tus.This stimulatorwas placed in Spain in 2011 and the patient
continued to use the stimulator at presentation. Stimulator
treatment was previously complicated by an infection, which
was treated with IV antibiotics and surgical debridement.
The patient reported pain relief from the stimulator, but she
was experiencing diminished relief from the stimulator over
the last several years and also had inadequate coverage in
her most painful region, which was the coccyx itself. She
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continued to have the stimulator turned on as it provided
some relief, but she was still incapacitated from the pain. She
was maintained on a pain medication regiment consisting
of oxycodone 10mg PO BID, dexketoprofen 25mg PO QID,
duloxetine 60mg PO QD, trazodone 100mg PO QD, and
pregabalin 75mg PO BID. Despite this intensive medical
treatment, the patient experienced poor symptom control in
addition to side effects from these medications, including
constipation and drowsiness.
The patient presented to us seeking other potential
options for pain relief, in particular a conventional radiofre-
quency ablation of the nerves innervating the coccyx or an
endoscopic radiofrequency ablation of those nerves. Consid-
ering the patient’s persistent severe coccydynia and failure
of extensive conservative and interventional treatments and
the chronicity of her pain, we proposed a DRG stimulator
trial in September of 2017. The use of DRG stimulation for
coccydynia is an off-label use; the reason we considered
DRG stimulation was secondary to our highly successful
experiences with DRG stimulation for both complex pelvic
and rectal pain, as well as low back and SI joint pain. Our
rationale for proceeding with the trial was the potential for
better regional coverage versus conventional sacral nerve
stimulation, similar to our experience in those cases.
Our proposed approach was a bilateral L1 and S2 DRG
stimulator trial.The patient decided to proceedwith theDRG
stimulator trial and underwent psychological clearance prior
to the procedure. During the 7-day trial, the patient rated
her pain less than 1/10 on visual analog score, improved sleep
hygiene, functioned better in general, and was actually able
to ambulate for approximately fourmiles without limitations.
Prior to the trial she could not walk more than a city block
without severe pain. She was able to function better in
almost all her daily activities and she was able to position
herself with minimal limitations and without the aid of her
cushion, which she previously carried with her at all times,
and claimed to have close to 100% coverage of her pain. After
the trial, the patient decided to proceed with permanent lead
implantation. She understood she had the option to have the
procedure performed in Europe or to have it performed at our
institute. After consideration, she decided to proceed with
the implantation at our center. We then decided to leave her
current spinal cord stimulator system in place rather than to
explant the system.
2.1. Surgical Procedure. A board-certified anesthesiologist
monitored the patient throughout the implant procedure.
Thirty minutes prior to the procedure the patient received
2 grams of cefazolin. The patient was placed in the prone
position with bolsters under the lumbar/lower thoracic
region. After positioning was deemed adequate, the patient
received propofol sedation. The lumbar spine and buttocks
were prepped and draped in normal sterile fashion with
betadine followed by DuraPrep. The L1 vertebral body was
then aligned on fluoroscopy and 1.0% lidocaine mixed with
0.5% bupivacaine was used for local anesthesia. A Tuohy
needle was inserted at the right side one level below the left
L1 target foramen at the level of the pedicle and was then
guided toward themidline at the interspace of the target level.
Figure 1: Anterior posterior fluoroscopic image of bilateral dorsal
root ganglion stimulation leads on the L1 level.
Figure 2: Lateral fluoroscopic image of bilateral dorsal root ganglion
stimulation leads on the L1 level.
Loss of resistance to air was achieved close to the midline. At
this point, the 4-contact DRG lead (Axium, St. Jude/Abbot,
Lake Bluff, IL) was loaded into the introducer catheter with
the lead tip approximately 2-3mm outside of the introducer.
The loaded introducerwas then passed into the Tuohy needle.
The introducer then accessed the epidural space and was
directed toward the foramen. The introducer was passed
through the target foramen until the middle two contacts
were under the level of the pedicle. The introducer was
then withdrawn to approximately 5mm after the proximal
contact while applying counterforce on the lead. A strain
relief loop was created in the usual fashion [4]. Subsequently,
the introducer was removed from the Tuohy needle and
the lead was left in place. Fluoroscopy was performed to
confirm no displacement of the lead had occurred. The same
procedure was performed to place a lead on the right L1 DRG.
Figures 1 and 2 depict the position of bilateral leads on the L1
level.
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Figure 3: Anterior posterior fluoroscopic image of bilateral dorsal
root ganglion stimulation leads on the S2 level. The trans-sacral-
hiatus octode lead and battery for her previous conventional sacral
neuromodulation therapy can be appreciated as well.
At this point the right S2 foramen was aligned under
fluoroscopy. A Tuohy needle was directed into the posterior
S2 foramen and its position was confirmed on fluoroscopy.
The lead loaded introducer was then passed through the
anterior foramen and the electrodes were maneuvered such
that the final position was with 1 contact anterior to the
anterior wall of the sacral vertebral body (extraforaminal), 2
contacts intrasacral, and 1 contact in the sacral epidural space.
A strain relief loop was created as previously described [4].
The introducer was then withdrawn into the Tuohy needle
with the lead left in place. In withdrawing the Tuohy needle
another small loop was placed subcutaneously for additional
tensile strength. The lead position was checked again in the
AP and lateral position. The same procedure was performed
to place a lead on the left S2 DRG. Figures 3 and 4 depict the
position of bilateral leads on the S2 level.
All 4 lead positions were then checked again and found to
be in good position as well as their tension loops. The leads
were then secured with Tegaderm. A marking was placed
on the right buttock that was 4 cm transverse in the upper
outer quadrant, since the patient’s ANS Genesis stimulator
was implanted on the left side. 10 cc of 1.0% lidocaine mixed
with 0.5% bupivacaine was used to anesthetize the incision
site. An incision was made and a pocket was created. The
leads were tunneled to the pocket as previously described
[5]. The leads were connected to the pulse generator and
impedances were confirmed. The incisions were irrigated
with Bacitracin solution and the generator was anchoredwith
2.0 Ethibond. The right buttock wound was closed in layers
by using 2.0 Vicryl and the skin was closed with staples.
All 4 lead puncture sites were small and the leads were
not visualized with manipulation of the puncture site. The
lead placement puncture sites and the buttock incision were
covered with Steristrips followed by gauze and Tegaderm.
On four-month follow-up, the patient still reports >90%
pain relief from the stimulator therapy with concomitant
improvements in daily functioning.The improvement in pain
Figure 4: Lateral fluoroscopic image of bilateral dorsal root gan-
glion stimulation leads on the S2 level. The trans-sacral-hiatus
octode lead for her previous conventional sacral neuromodulation
therapy can be appreciated as well.
control allowed her to discontinue her oxycodone, which was
causing her to suffer from side effects before.
3. Discussion
The aim of this report was to describe the successful appli-
cation of DRG stimulation for chronic coccydynia. Coccy-
dynia is prevalent and can be difficult to treat in chronic
cases. Factors associated with increased risk of developing
coccydynia include obesity and female gender [6]; women
are 5 times more likely to develop coccydynia than men. The
most common etiology of coccydynia is trauma, consistent
with the presented case. External trauma usually occurs
due to a backwards fall, leading to a bruised, dislocated, or
broken coccyx [7]. Patients typically present complaining of
“tailbone pain.”Thepainwill usually beworsewith prolonged
sitting, leaning back while seated, prolonged standing, and
rising from a seated position. X-ray and magnetic reso-
nance imaging can be used to evaluate for the presence of
fractures, degenerative changes, or masses. Most cases of
coccydynia resolve within weeks to months with or without
conservative treatment [8]. Conservative treatment consists
of cushions, the application of heat and cold, nonsteroidal
anti-inflammatory drugs, and transcutaneous electrical nerve
stimulation.
For the few cases that do not respond to these conserva-
tive treatments,more aggressive treatmentsmay be indicated.
Injections around the coccyx, usually at the sacrococcygeal
junction or around the sacrococcygeal ligaments, of local
anesthetic with steroid can be both diagnostic and therapeu-
tic [9]. Another approach is to target the ganglion impar,
also known as the ganglion of Walther [10]. The ganglion
impar is the pelvic portion of the sympathetic trunk located
in the midline anterior to the sacrococcygeal junction. This
block can be useful in refractory cases and cases associ-
ated with pelvic pain, as well as for pain associated with
malignant neoplasms. Surgical procedures for the treatment
4 Case Reports in Anesthesiology
of coccydynia have been reported consisting of surgical
amputation of the coccyx just proximal to the sacrococcygeal
junction [11]. However, this procedure may be associated
with a high complication rate and failure to relieve the pain.
Consequently, based on current available information, this
procedure generally is not recommended [2].
Recent case reports support the use of different neu-
romodulation techniques to treat refractory coccydynia. In
2008 Haider [12] reported on the use of conventional spinal
cord stimulation to successfully treat a patient with chronic
coccydynia. Another report by Vajramani et al. [13] described
the successful use of high frequency 10 kHz spinal cord
stimulation to the conus/cauda region in two patients with
chronic coccydynia. Our report adds to this by describing
the successful application of DRG stimulation for coccydy-
nia. The DRG has been of interest to pain physicians for
years since scientific evidence on spinal structures suggests
that the DRG is an integral part of both nociceptive and
neuropathic pain states [14]. The suggested mechanism of
electrical stimulation of the DRG is a reduction of action
potential conduction at the bifurcation (T-junction) of sen-
sory neurons within the DRG, resulting in the reduction
of perceived pain [15]. Most studies to date have focused
on DRG stimulation for neuropathic pain states [14]. Both
neuropathic and nociceptive components are believed to
contribute to chronic coccydynia [3], and the instrumental
role of the DRG in both pain states may explain the positive
results achieved in the present case.
3.1. Conclusion. We successfully used DRG stimulation to
treat chronic coccydynia. Future studies need to corroborate
the effectiveness of DRG stimulation for this indication.
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